Synergy CHC Corp. Watch

EX-10.39

from S-1/A 3 pages Amended and Restated Promissory Note

12/34/56

EX-10.39

from S-1/A 1 page Signatures to Follow

12/34/56

EX-10.5

from S-1/A 21 pages Synergy CHC Corp. 2024 Equity Incentive Plan

12/34/56

EX-10.38

from S-1 12 pages Indemnification Agreement

12/34/56

EX-10.37

from S-1 10 pages Modification Agreement

12/34/56

EX-10.36

from S-1 10 pages Modification Agreement

12/34/56

EX-10.35

from S-1 13 pages Senior Subordinated Debenture Due September 8, 2022

12/34/56

EX-10.34

from S-1 40 pages Securities Purchase Agreement

12/34/56

EX-10.33

from S-1 1 page Signatures to Follow

12/34/56

EX-10.30

from S-1 11 pages Master Vendor Agreement

12/34/56

EX-10.29

from S-1 18 pages Supplier Agreement

12/34/56

EX-10.28

from S-1 7 pages Costco Wholesale Basic Vendor Agreement United States (2004) Factor Nutrition Labs LLC (“Vendor”) and Costco Wholesale Corporation (Referred to as “Costco Wholesale”) Agree That

12/34/56

EX-10.27

from S-1 11 pages Distribution Agreement

12/34/56

EX-10.26

from S-1 11 pages Distribution Agreement

12/34/56

EX-10.25

from S-1 13 pages Distribution Agreement

12/34/56

EX-10.24

from S-1 9 pages Distribution Agreement

12/34/56

EX-10.23

from S-1 13 pages Sixth Amendment Agreement Entered Into as June 6, 2024 (This “Sixth Amendment”),

12/34/56

EX-10.22

from S-1 15 pages Fifth Amendment Agreement Entered Into as of September 30, 2023 (This “Fifth Amendment”), Between: Knight Therapeutics International S.A., a Company Registered Under the Laws of Uruguay (Formerly Known as Knight Therapeutics (Barbados) Inc.); (Hereinafter Called the “Lender”) And: Synergy CHC Corp., a Corporation Formed Under the Laws of the State of Nevada;

12/34/56

EX-10.21

from S-1 13 pages Article 1 Interpretation

12/34/56

EX-10.20

from S-1 12 pages (Hereinafter Called the “Borrower”) Article 1 Interpretation

12/34/56